ResMed (RMD) July out of the money puts active as share price down 12%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Oppenheimer Downgrades ResMed (RMD) to Perform
June 25, 2024 6:02 AM EDTOppenheimer analyst Suraj Kalia downgraded ResMed (NYSE: RMD) from Outperform to Perform.
The analyst comments "SURMOUNT-OSA dataset was presented at ADA (NEJM link) on 06/21. While we have discussed GLP-1s/SURMOUNT-OSA at length and the risk we believe they represent to the... More



